Literature DB >> 15939634

JAK-STAT signaling pathway in pulmonary arterial smooth muscle cells is activated by hypoxia.

Guan-Song Wang1, Gui-Sheng Qian, De-Shan Zhou, Ji-Qing Zhao.   

Abstract

Pulmonary arterial smooth muscle cells (PASMC) were divided into a normoxic group (N), 2, 8 and 12 h hypoxic groups (H2, H8 and H12) and an AG490 plus 8 h hypoxic group (AG490). The expression of JAK1, JAK2, JAK3 and TYK2 mRNA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). STAT1 and STAT3 protein expressions were determined by Western blotting. The results showed that the levels of JAK1, JAK2 and JAK3 mRNA did not change significantly in the N group but were increased after 2 h exposure to hypoxia. JAK1, JAK2 and JAK3 mRNA expressions peaked at 8 h. It decreased at 12 h but remained above those in the N group. TYK2 mRNA was not found in either hypoxic or normal PASMC. The phospho-STAT1 and -STAT3 protein levels increased after 2 h exposure to hypoxia. They were about 2.8 and 4.1 times the N group, respectively, after 8 h. They decreased at 12 h but remained above those in the N group. AG490 inhibited phospho-STAT3 protein expression by about 25.5% at 8 h but did not block the expression of phospho-STAT1 protein. These findings suggest that hypoxia induces the expression of JAK1, JAK2, JAK3 and phospho-STAT1 and -STAT3 in PASMC. Hypoxia activates the JAKs-STATs signaling pathway, which may participate in the pathogenesis of hypoxic PASMC injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939634     DOI: 10.1016/j.cellbi.2005.03.014

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

1.  Regulation of Voltage-Gated K+ Channel Kv1.5 by the Janus Kinase JAK3.

Authors:  Jamshed Warsi; Bernat Elvira; Rosi Bissinger; Zohreh Hosseinzadeh; Florian Lang
Journal:  J Membr Biol       Date:  2015-06-23       Impact factor: 1.843

2.  JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.

Authors:  Longfei Pan; Zhuo Peng; Ruipeng Zhang; Rui Zhang; Dean Liang; Heming Chen; Hongyan Tian
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-15

3.  Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia.

Authors:  Guansong Wang; Zhiyuan Zhang; Zhi Xu; Hongjin Yin; Li Bai; Zhuang Ma; Mark A Decoster; Guisheng Qian; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2010-09-15

4.  Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.

Authors:  Guansong Wang; Pin Qian; Fannie R Jackson; Guisheng Qian; Guangyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

5.  Phosphorylation of STAT3 and ERBB2 mediates hypoxia‑induced VEGF release in ARPE‑19 cells.

Authors:  Soohyun Hwang; Hyemin Seong; Jinhyun Ryu; Joo Yeon Jeong; Tae Seen Kang; Ki Yup Nam; Seong Wook Seo; Seong Jae Kim; Sang Soo Kang; Yong Seop Han
Journal:  Mol Med Rep       Date:  2020-07-16       Impact factor: 2.952

6.  Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis.

Authors:  Brandy E Wade; Jingru Zhao; Jing Ma; C Michael Hart; Roy L Sutliff
Journal:  Pulm Circ       Date:  2018-06-21       Impact factor: 3.017

Review 7.  The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.

Authors:  Inés Roger; Javier Milara; Paula Montero; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

8.  Survival response of hippocampal neurons under low oxygen conditions induced by Hippophae rhamnoides is associated with JAK/STAT signaling.

Authors:  Manimaran Manickam; Rajkumar Tulsawani
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

Review 9.  Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Ina Yosifova Aneva; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.